The intravenous (IV) ibuprofen market is witnessing a robust phase of expansion, driven by advancements in drug delivery systems and increased adoption in hospital settings for pain and inflammation management. Market companies are focusing on enhancing formulations to reduce side effects and improve efficacy, aligning with evolving healthcare standards. https://www.coherentmarketinsights.com/industry-reports/intravenous-ibuprofen-market